Mauna Kea Technologies SAS (MKEA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mauna Kea Technologies SAS (MKEA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3446
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicroscopy platform that provides microscopic images of tissue instantaneously and in a minimally-invasive way. The company also offers vasculature and vasodynamics studies, longitudinal monitoring of disease progression and in vivo histology. It provides technical support and training. MKT’s products are used for treatment of digestive diseases and diagnosing respiratory diseases and also used in laboratories for research on small animals. The company has presence in North America, Europe and Asia. MKT is headquartered in Paris, France.

Mauna Kea Technologies SAS (MKEA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mauna Kea Technologies SAS, Medical Devices Deals, 2012 to YTD 2018 9
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Mauna Kea Technologies to Raise USD9.1 Million in Public Offering of Shares 11
Mauna Kea Technologies to Raise USD5.7 Million in Public Offering of Shares 12
Debt Offering 13
Mauna Kea Tech Raises USD4.3 Million in First Tranche of Private Placement of Bonds Due 2022 13
Mauna Kea Technologies SAS – Key Competitors 14
Mauna Kea Technologies SAS – Key Employees 15
Mauna Kea Technologies SAS – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Sep 20, 2017: Mauna Kea Technologies Reports First Half 2017 Financial Results 17
Jul 25, 2017: Mauna Kea Technologies Reports First Half 2017 Sales 19
Apr 19, 2017: Mauna Kea Technologies Reports First Quarter 2017 Sales 20
Mar 23, 2017: Mauna Kea Technologies Reports Full Year 2016 Financial Results And Highlights 2017 Key Priorities 21
Jan 24, 2017: Mauna Kea Technologies Reports Fourth Quarter and Full Year 2016 Sales 23
Corporate Communications 24
Apr 05, 2018: Appointment of Christophe Lamboeuf to the position of Chief Financial Officer 24
Jan 15, 2018: Mauna Kea Technologies Appoints Experienced Healthcare Executive, Molly O’Neill, to Board of Directors 25
Oct 17, 2017: Mauna Kea Technologies Appoints Olivier Regnard as Deputy CEO And Chief Financial Officer 26
Mar 13, 2017: Mauna Kea Appoints Jennifer F. Tseng, M.D. to Board of Directors 27
Other Significant Developments 28
Jul 25, 2018: Mauna Kea Technologies Reports Second Quarter and First Half 2018 Sales 28
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mauna Kea Technologies SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Mauna Kea Technologies SAS, Medical Devices Deals, 2012 to YTD 2018 9
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Mauna Kea Technologies to Raise USD9.1 Million in Public Offering of Shares 11
Mauna Kea Technologies to Raise USD5.7 Million in Public Offering of Shares 12
Mauna Kea Tech Raises USD4.3 Million in First Tranche of Private Placement of Bonds Due 2022 13
Mauna Kea Technologies SAS, Key Competitors 14
Mauna Kea Technologies SAS, Key Employees 15
Mauna Kea Technologies SAS, Subsidiaries 16

List of Figures
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mauna Kea Technologies SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Mauna Kea Technologies SAS (MKEA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • genedrive plc (GDR):企業の財務・戦略的SWOT分析
    genedrive plc (GDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Ion Beam Applications SA (IBAB):医療機器:M&Aディール及び事業提携情報
    Summary Ion Beam Applications SA (IBA) develops solutions for the diagnosis and treatment of cancer. It offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The company focuses its activities on proton therapy solut …
  • Hitachi Ltd (6501):企業の財務・戦略的SWOT分析
    Hitachi Ltd (6501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • BORSIG ZM Compression GmbH:企業の戦略的SWOT分析
    BORSIG ZM Compression GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Tiziana Life Sciences Plc (TILS):製薬・医療:M&Aディール及び事業提携情報
    Summary Tiziana Life Sciences Plc (Tiziana), formerly Alexander David Investments Plc, is a clinical stage biotechnology company that discovers and develops drugs to treat diseases in oncology and immunology. The company’s lead product candidate, TZLS-201, intended for the treatment of thymic carcin …
  • gel-e Inc:医療機器:M&Aディール及び事業提携情報
    Summary gel-e Inc (gel-e), formerly Remedium Technologies Inc, is a medical device company that provides products for the treatment of acute wounds. The company provides spray foams, bandages, gels, films, and band-aids. It provides proprietary technology platform that helps develop wound treatment …
  • Subsea 7 SA (SUBC):電力:M&Aディール及び事業提携情報
    Summary Subsea 7 SA (Subsea 7) is a contractor in seabed-to-surface engineering, construction and services. The company provides engineering, project management, supply chain, and vessel management services. It connects seabed wellhead structures to surface facilities, such as platforms and floating …
  • Tana Exploration Company LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Tana Exploration Company LLC (Tana Exploration) is an oil and gas exploration and development company that develops oil and gas resources. The company's products include natural gas and crude oil. It provides services such as technical support, financial support, and remodeling services. Tan …
  • Petroleos Mexicanos-石油・ガス分野:企業M&A・提携分析
    Summary Petroleos Mexicanos (PEMEX) is a state owned vertically integrated oil and gas company. The company explores for, develops and produces crude oil and natural gas. It also refines and markets petroleum products. PEMEX gathers and processes natural gas products. It manufactures and markets a w …
  • ROHA Dyechem Pvt. Ltd.:企業の戦略・SWOT・財務情報
    ROHA Dyechem Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary ROHA Dyechem Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kratos Defense & Security Solutions, Inc.:企業のM&A・事業提携・投資動向
    Kratos Defense & Security Solutions, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kratos Defense & Security Solutions, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • LEM Holding SA (LEHN):企業の財務・戦略的SWOT分析
    LEM Holding SA (LEHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • University of California:製薬・医療:M&Aディール及び事業提携情報
    Summary University of California is a public research university system that offers educational and research services. The university’ services include research and teaching services, graduate, undergraduate and postgraduate courses, doctoral programs and courses, master’s programs, degree programs, …
  • HD Biosciences (China) Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary HD Biosciences (China) Co Ltd (HDB), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a contract research organization that offers drug discovery research services. The organization develops and provides products such as mycoplasma detection kit and wash free calcium assay kit, among others …
  • Claverack Rural Electric Cooperative Inc:企業の戦略的SWOT分析
    Claverack Rural Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Bank of the Philippine Islands:企業の戦略・SWOT・財務情報
    Bank of the Philippine Islands - Strategy, SWOT and Corporate Finance Report Summary Bank of the Philippine Islands - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Agilvax Inc-製薬・医療分野:企業M&A・提携分析
    Summary Agilvax Inc (Agilvax) is a drug company that discovers and develops vaccines against infectious diseases and immunotherapies to treat cancer. The company develops products based on a proprietary virus-like particle platform technology. It develops immunotherapies to treat breast cancer, lung …
  • Cabela’S Inc:企業の戦略・SWOT・財務分析
    Cabela'S Inc - Strategy, SWOT and Corporate Finance Report Summary Cabela'S Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Stryker Corp (SYK):企業の財務・戦略的SWOT分析
    Stryker Corp (SYK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Futura Medical Plc (FUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Futura Medical Plc (Futura Medical) is a pharmaceutical company that focuses on research and development of novel products for various therapeutic areas, including sexual health and pain relief management. The company focuses on developing pharmaceutical products based on its transdermal dru …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆